Skip to main content

Medicaid Drug Fraud: Federal Leadership Needed to Reduce Program Vulnerabilities

T-HRD-93-28 Published: Aug 02, 1993. Publicly Released: Aug 02, 1993.
Jump To:
Skip to Highlights

Highlights

GAO discussed Medicaid prescription drug diversion. GAO noted that: (1) some pharmacists routinely add medications to customers' orders to keep for themselves or sell to others; (2) some clinics inappropriately provide Medicaid recipients with completed prescription forms that are traded for merchandise from local pharmacies or sold on the street to the highest bidder; (3) patients often allow use of their Medicaid recipient numbers for billing purposes in exchange for cash, drugs, or other inducements; (4) prescription drugs cost Medicaid $5.5 billion in 1991 and expenditures for prescriptions tripled between 1975 and 1990; and (5) states have instituted controls and measures to prevent Medicaid fraud and facilitate pursuit, punishment, and financial recovery.

Full Report

Office of Public Affairs

Topics

CollusionControlled substancesDrugsEntitlement programsFraudMedicaidMedical expense claimsPharmaceutical industryPhysiciansWelfare recipientsPrescription drugs